Mesoblast Limited (MESO)

Every figure this model derived for MESO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 680,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-06-30
cash 129,975,000 CashAndCashEquivalents 2025-12-31
current assets 202,483,000 CurrentAssets 2025-12-31
current liabilities 128,069,000 CurrentLiabilities 2025-12-31
equity 574,684,000 Equity 2025-12-31
interest expense 21,753,000 InterestExpense 2025-06-30
ocf -49,954,000 CashFlowsFromUsedInOperatingActivities 2025-06-30
revenue 17,198,000 Revenue 2025-06-30
sbc 9,200,000 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MESO on one particular measure came for.

RatioValue
current ratio1.58
current ratio reported1.58
dilution pct22.42
fcf margin-294.42
growth cv4.45
owner earnings margin-347.91
revenue growth191.39
revenue growth per share138.02
sbc pct revenue53.49

What to be careful about

What this model itself distrusts about MESO's figures. Written by the derivation as it ran, not added afterwards.